Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its ...

Shin Yoo-yeol networks at JP Morgan conference as Lotte Biologics seeks contracts Shin Yoo-yeol makes inaugural appearance at ...

Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

J.P. Morgan releases its quarterly look-ahead days before the entire biopharma industry descends on San Francisco for the ...

Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P ...

The 43rd J.P. Morgan Healthcare Conference in San Francisco will see active participation by Korean pharmaceutical giants and ...

A live webcast of the presentation can be accessed on the “Events & Presentations” page in the Investor section of Korro’s website at www.korrobio.com. Following the presentation, a replay of the ...

“Despite industry challenges, Samsung Biologics is well positioned to kick-start a new phase of growth in 2025 with the ...

Celltrion leaders unveil global drug development plans at JP Morgan Conference Celltrion prepares to showcase ambitious drug ...

J.P. Morgan is hosting a three-panel women's health series at this year's conference to highlight the importance of ...

Lyell is focused on advancing next-generation CAR T cell therapies with the potential to deliver higher response rates and ...